Management of Episodic Migraine with Neuromodulation: A Case Report

Dent Clin North Am. 2023 Jan;67(1):157-171. doi: 10.1016/j.cden.2022.07.012. Epub 2022 Oct 27.

Abstract

Migraine is a highly prevalent neurovascular disorder that affects approximately 15% of the global population. Migraine attacks are a complex cascade of neurologic events that lead to debilitating symptoms and are often associated with inhibitory behavior. The constellation of severe signs and symptoms during the ictal phase (headache attack) makes migraine the third most common cause of disability globally in both sexes under the age of 50. Misuse of pharmaceuticals, such as opiates, can lead to devastating outcomes and exacerbation of pain and headache attacks. A safe and well-tolerated non-pharmacological research approach is high-definition transcranial direct current stimulation over the M1.

Keywords: Migraine; Neuromodulation; Primary motor cortex (M1); Transcranial direct current stimulation.

Publication types

  • Case Reports
  • Review
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Female
  • Headache
  • Humans
  • Male
  • Migraine Disorders* / diagnosis
  • Migraine Disorders* / therapy
  • Transcranial Direct Current Stimulation*